Agencies and Organizations
Subscribe to Agencies and Organizations

The Lead

Rhodes Pharmaceuticals' announces launch of daily treatment for ADHD

May 22, 2015 9:59 am | by PRNewswire | News | Comments

Today, Rhodes Pharmaceuticals L.P. announced that Aptensio XR, a once-daily central nervous system stimulant indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) will be available to patients beginning Summer 2015.

EMA recommends suspending medicines over flawed studies

May 22, 2015 9:31 am | News | Comments

The European Medicines Agency (EMA) has confirmed its recommendation to suspend a number of...

DEA raids clinics, pharmacies in 'pill mill' crackdown

May 21, 2015 11:46 am | by CLAUDIA LAUER & ALICIA A. CALDWELL, Associated Press | News | Comments

Authorities raided medical clinics, pharmacies and other locations across the South on Wednesday...

FDA Cautions About Dose Confusion and Medication Errors

May 21, 2015 10:23 am | News | Comments

The U.S. Food and Drug Administration (FDA) is warning health care professionals about the risk...

View Sample

FREE Email Newsletter

USP demands public standards for dietary supplements

May 21, 2015 10:06 am | by United States Pharmacopeial Convention | News | Comments

In recent weeks, the case of supplements containing an amphetamine-like substance called BMPEA has prompted FDA recalls; industry trade group condemnation; appeals from Congress for increased enforcement, consumer education campaigns and greater participation by ...

EMA: Compare Drug Combinations With Individual Components

May 20, 2015 10:51 am | by FDA | News | Comments

Sponsors seeking EU authorization to market fixed-dose drug combinations should conduct multiarm, randomized, controlled trials comparing the FDC with its individual components, the European Medicines Agency says.

Investigational Hep C Drugs Receive Breakthrough Therapy Designation

May 20, 2015 10:20 am | by Business Wire | News | Comments

Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has amended a previously granted Breakthrough Therapy Designation for the investigational daclatasvir and sofosbuvir combination for use in hepatitis C (HCV) patients.


FDA approves new medication to treat schizophrenia

May 20, 2015 10:12 am | by Janssen Pharmaceuticals | News | Comments

There’s a new treatment option for schizophrenia – INVEGA TRINZA (three-month paliperidone palmitate), the first and only schizophrenia medication to be administered just four times a year, providing the longest dosing interval available.

Eagle Pharmaceuticals Receives Patent for Rapid Infusion Product

May 19, 2015 8:59 am | by Business Wire | Teva Pharmaceuticals Usa | News | Comments

Eagle Pharmaceuticals, Inc. today announced that the United States Patent and Trademark Office (“USPTO”) has granted U.S. Patent No. 9,034,908, which pertains to the use of the bendamustine hydrochloride (HCl) formulation administered in a 50mL bag within ten minutes.

Merkel: Global Catastrophe Plan Needed After Ebola Crisis

May 18, 2015 1:06 pm | by KIRSTEN GRIESHABER, Associated Press | News | Comments

The Ebola crisis in western Africa showed the world in a painful way that a global catastrophe plan is needed to deal with future epidemics, German Chancellor Angela Merkel said Monday. "The struggle (against Ebola) is only won if there are no new ...

FTC Seeks More Info From Pfizer About Hospira Acquisition

May 15, 2015 12:04 pm | by Pfizer Inc. | News | Comments

Pfizer Inc. today announced that it has received a request for additional information from the FTC with respect to its previously announced proposed acquisition of Hospira.

Puma Biotech Stumbles With Breast Cancer Drug

May 15, 2015 11:53 am | by The Associated Press | News | Comments

Treatment results with the breast cancer drug Herceptin, as well as chemotherapy, did improve, but the drug's backers had been hoping to see better results.


Continuing Story: Judge Won't Toss Out FedEx Drug Indictment

May 15, 2015 11:47 am | by Sudhin Thanawala, Associated Press | News | Comments

U.S. District Court Judge Charles Breyer said the acts alleged by prosecutors do not fall under an exemption in federal drug law for transportation companies such as FedEx.

10-lb. Packages of Marijuana Wash Ashore in 2 States

May 15, 2015 11:35 am | by The Associated Press | News | Comments

Beach dwellers in Alabama and North Carolina have stumbled upon bulky packages worth thousands of dollars.

Colombian Ban on Anti-Coca Herbicide is Bittersweet

May 14, 2015 11:54 am | by Jacobo Garcia, Associated Press | News | Comments

Colombian President Santos last week decided to halt fumigation in the wake of a report by a research arm of the World Health Organization classifying (anti-coca) glyphosate as a probable carcinogen.

FedEx Seeks Dismissal of Federal Drug Indictment

May 14, 2015 11:41 am | by The Associated Press | News | Comments

Attorneys for FedEx are set to appear in court, as they seek to dismiss a federal indictment that accuses the company of knowingly shipping illegal prescription drugs from two online pharmacies.

FDA Panel Backs Vertex Combination Pill for Cystic Fibrosis

May 13, 2015 11:23 am | by Matthew Perrone, AP Health Writer | News | Comments

Federal health advisers recommended approval for an experimental combination drug to treat cystic fibrosis, despite unresolved questions about the benefit of one of the pill's two ingredients.


Panel Calls for Change at WHO After Slow Ebola Response

May 12, 2015 11:20 am | by Krista Larson, Associated Press | News | Comments

An independent panel of experts said Monday that "deep and substantial" change is needed at the WHO following its slow response to early warnings about West Africa's Ebola outbreak.

Liberia Cautiously Marks End of Ebola

May 11, 2015 10:55 am | by Jonathan Paye-Layleh and Krista Larson, Associated Press | News | Comments

Saturday marked 42 days since Liberia's last Ebola case — the benchmark used to declare the outbreak over. The epidemic claimed more than 4,700 lives in the country.

FDA Fast Tracks Sucampo's Cobiprostone

May 11, 2015 10:28 am | by Sucampo Pharmaceuticals | News | Comments

The FDA has granted Fast Track Designation for cobiprostone, a locally acting chloride channel activator for the prevention of oral mucositis.

FDA Questions Benefit of Cystic Fibrosis Drug From Vertex

May 8, 2015 11:39 am | by Matthew Perrone, AP Health Writer | News | Comments

The Food and Drug Administration said in an online review that the benefit was small and it is unclear if the addition of a second drug ingredient adds to the pill's effectiveness.

Ebola is Found in Doctor's Eye Months After Virus Left Blood

May 8, 2015 11:33 am | by Marilynn Marchione, AP Chief Medical Writer | News | Comments

For the first time, Ebola has been discovered inside the eyes of a patient months after the virus was gone from his blood.

Synthetic Pot Leads to Nationwide Spike in Hospitalizations

May 8, 2015 11:29 am | by Dave Collins, Associated Press | News | Comments

A huge nationwide spike in hospitalizations last month was caused by a class of drugs often called synthetic marijuana, possibly illustrating the potency and dangers of the chemicals used to make them.

Kalorama: Insulin Pump Market Growing Robustly

May 8, 2015 11:10 am | by Kalorama Information | News | Comments

The growth in the insulin pump market is driven by the aging population, increasing incidence of diabetes, expanding global markets, new product innovations and increasing life expectancy.

Mylan Launches Generic Seasonale Tablets

May 7, 2015 11:50 am | by Mylan N.V. | News | Comments

Mylan N.V. today announced the U.S. launch of Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.15 mg/0.03 mg, which is the generic version of Teva's Seasonale Tablets.

Teva Announces Adrucil Recall

May 5, 2015 11:44 am | News | Comments

Teva announced a voluntary recall of eight lots of Adrucil (fluorouracil injection, USP) 5 g/100 mL (50 mg/mL) due to the potential presence of particulate matter.

Topical Treatment CMO Continues Expansion

May 5, 2015 9:55 am | by Mike Auerbach, Editor-In-Chief | Blogs | Comments

Dow Development Laboratories in California is working to position itself as the "go-to" contract manufacturer for topical product development services.

FDA Approves Spray-On Surgical Sealant

May 1, 2015 10:46 am | by FDA | News | Comments

The FDA today approved Raplixa, the first spray-dried fibrin sealant approved by the agency. It is used to help control bleeding during surgery.

Vernalis, Tris Pharma Receive FDA Approval for Tuzistra XR

May 1, 2015 10:36 am | by Vernalis | News | Comments

Tuzistra XR is an extended-release oral suspension combination of codeine and chlorpheniramine in treating coughs and upper respiratory allergies.

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.